ARCHIVES

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

McKesson To Purchase US Oncology

November 5, 2010

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

Reauthorization Still Held up

September 30, 1988

Bourne Tells ACCC White House Backs Hospice Concept

May 12, 1978

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

October 10, 1980